F31 GM20068-01/GM/NIGMS NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2000	1
2002	1
2003	1
2025	0

Page 1

A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study.

García F, Plana M, Arnedo M, Ortiz GM, Miró JM, Lopalco L, Lori F, Pumarola T, Gallart T, Gatell JM. García F, et al. AIDS. 2003 Jan 3;17(1):43-51. doi: 10.1097/00002030-200301030-00007. AIDS. 2003. PMID: 12478068 Clinical Trial.

Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection.

Bonhoeffer S, Rembiszewski M, Ortiz GM, Nixon DF. Bonhoeffer S, et al. AIDS. 2000 Oct 20;14(15):2313-22. doi: 10.1097/00002030-200010200-00012. AIDS. 2000. PMID: 11089619

Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8+ T-cell responses in subjects treated early after infection.

Ortiz GM, Hu J, Goldwitz JA, Chandwani R, Larsson M, Bhardwaj N, Bonhoeffer S, Ramratnam B, Zhang L, Markowitz MM, Nixon DF. Ortiz GM, et al. J Virol. 2002 Jan;76(1):411-5. doi: 10.1128/jvi.76.1.411-415.2002. J Virol. 2002. PMID: 11739706 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year